Global Mental Disorder Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 152 pages | ID: G3BB590246B8EN
LP Information

Abstracts

According to this study, the global Mental Disorder Treatment market size will reach US$ 83000 million by 2031.

A mental disorder is also called as mental illness or a psychiatric disorder. Mental disorders are generally defined according to how an individual behave, feels, perceives and thinks, and mental disorder occurs due to damage or problems associated with functions of brain. There are various types of mental disorders such as depression, bipolar disorder, schizophrenia and other psychoses, dementia, and developmental disorders including autism.

These disorders can be treated with the help of various medications such as anti-depressants, antianxiety drugs and can also be treated with self-help therapies such as psychotherapy, brain stimulation treatments, and others.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Mental Disorder Treatment Industry Forecast” looks at past sales and reviews total world Mental Disorder Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Mental Disorder Treatment sales for 2025 through 2031. With Mental Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mental Disorder Treatment industry.

This Insight Report provides a comprehensive analysis of the global Mental Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mental Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mental Disorder Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mental Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mental Disorder Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Mental Disorder Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Medications
• Self-help Therapies

Segmentation by Application:

• Depression
• Bipolar Disorder
• Schizophrenia
• Dementia
• Post-traumatic Stress Disorder
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Allergan Plc
• Eli Lilly and Company
• VistaGen Therapeutics
• Sanofi S.A
• Novartis International AG
• Mylan N.V
• Amneal Pharmaceuticals LLC
• Cipla Ltd
• Sun Pharmaceutical Industries Ltd
• Glenmark Pharmaceuticals Limited
• Lupin Limited
• Janssen Pharmaceutica
• Bristol Myers Squibb
• Sumitomo Dainippon Pharma Co., Ltd
• Acadia Healthcare
• The MENTOR Network
• Universal Health Services, Inc.
• Behavioral Health Network, Inc.
• CareTech Holdings PLC
• Strategic Behavioral Health
• Ascension Seton
• North Range Behavioral Health
• Pyramid Healthcare
• Promises Behavioral Health

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mental Disorder Treatment Market Size (2020-2031)
  2.1.2 Mental Disorder Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Mental Disorder Treatment by Country/Region (2020, 2024 & 2031)
2.2 Mental Disorder Treatment Segment by Type
  2.2.1 Medications
  2.2.2 Self-help Therapies
2.3 Mental Disorder Treatment Market Size by Type
  2.3.1 Mental Disorder Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Mental Disorder Treatment Market Size Market Share by Type (2020-2025)
2.4 Mental Disorder Treatment Segment by Application
  2.4.1 Depression
  2.4.2 Bipolar Disorder
  2.4.3 Schizophrenia
  2.4.4 Dementia
  2.4.5 Post-traumatic Stress Disorder
  2.4.6 Others
2.5 Mental Disorder Treatment Market Size by Application
  2.5.1 Mental Disorder Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Mental Disorder Treatment Market Size Market Share by Application (2020-2025)

3 MENTAL DISORDER TREATMENT MARKET SIZE BY PLAYER

3.1 Mental Disorder Treatment Market Size Market Share by Player
  3.1.1 Global Mental Disorder Treatment Revenue by Player (2020-2025)
  3.1.2 Global Mental Disorder Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Mental Disorder Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MENTAL DISORDER TREATMENT BY REGION

4.1 Mental Disorder Treatment Market Size by Region (2020-2025)
4.2 Global Mental Disorder Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mental Disorder Treatment Market Size Growth (2020-2025)
4.4 APAC Mental Disorder Treatment Market Size Growth (2020-2025)
4.5 Europe Mental Disorder Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Mental Disorder Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Mental Disorder Treatment Market Size by Country (2020-2025)
5.2 Americas Mental Disorder Treatment Market Size by Type (2020-2025)
5.3 Americas Mental Disorder Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mental Disorder Treatment Market Size by Region (2020-2025)
6.2 APAC Mental Disorder Treatment Market Size by Type (2020-2025)
6.3 APAC Mental Disorder Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Mental Disorder Treatment Market Size by Country (2020-2025)
7.2 Europe Mental Disorder Treatment Market Size by Type (2020-2025)
7.3 Europe Mental Disorder Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mental Disorder Treatment by Region (2020-2025)
8.2 Middle East & Africa Mental Disorder Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Mental Disorder Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MENTAL DISORDER TREATMENT MARKET FORECAST

10.1 Global Mental Disorder Treatment Forecast by Region (2026-2031)
  10.1.1 Global Mental Disorder Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Mental Disorder Treatment Forecast
  10.1.3 APAC Mental Disorder Treatment Forecast
  10.1.4 Europe Mental Disorder Treatment Forecast
  10.1.5 Middle East & Africa Mental Disorder Treatment Forecast
10.2 Americas Mental Disorder Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Mental Disorder Treatment Forecast
  10.2.2 Canada Market Mental Disorder Treatment Forecast
  10.2.3 Mexico Market Mental Disorder Treatment Forecast
  10.2.4 Brazil Market Mental Disorder Treatment Forecast
10.3 APAC Mental Disorder Treatment Forecast by Region (2026-2031)
  10.3.1 China Mental Disorder Treatment Market Forecast
  10.3.2 Japan Market Mental Disorder Treatment Forecast
  10.3.3 Korea Market Mental Disorder Treatment Forecast
  10.3.4 Southeast Asia Market Mental Disorder Treatment Forecast
  10.3.5 India Market Mental Disorder Treatment Forecast
  10.3.6 Australia Market Mental Disorder Treatment Forecast
10.4 Europe Mental Disorder Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Mental Disorder Treatment Forecast
  10.4.2 France Market Mental Disorder Treatment Forecast
  10.4.3 UK Market Mental Disorder Treatment Forecast
  10.4.4 Italy Market Mental Disorder Treatment Forecast
  10.4.5 Russia Market Mental Disorder Treatment Forecast
10.5 Middle East & Africa Mental Disorder Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Mental Disorder Treatment Forecast
  10.5.2 South Africa Market Mental Disorder Treatment Forecast
  10.5.3 Israel Market Mental Disorder Treatment Forecast
  10.5.4 Turkey Market Mental Disorder Treatment Forecast
10.6 Global Mental Disorder Treatment Forecast by Type (2026-2031)
10.7 Global Mental Disorder Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Mental Disorder Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Allergan Plc
  11.1.1 Allergan Plc Company Information
  11.1.2 Allergan Plc Mental Disorder Treatment Product Offered
  11.1.3 Allergan Plc Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Allergan Plc Main Business Overview
  11.1.5 Allergan Plc Latest Developments
11.2 Eli Lilly and Company
  11.2.1 Eli Lilly and Company Company Information
  11.2.2 Eli Lilly and Company Mental Disorder Treatment Product Offered
  11.2.3 Eli Lilly and Company Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Eli Lilly and Company Main Business Overview
  11.2.5 Eli Lilly and Company Latest Developments
11.3 VistaGen Therapeutics
  11.3.1 VistaGen Therapeutics Company Information
  11.3.2 VistaGen Therapeutics Mental Disorder Treatment Product Offered
  11.3.3 VistaGen Therapeutics Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 VistaGen Therapeutics Main Business Overview
  11.3.5 VistaGen Therapeutics Latest Developments
11.4 Sanofi S.A
  11.4.1 Sanofi S.A Company Information
  11.4.2 Sanofi S.A Mental Disorder Treatment Product Offered
  11.4.3 Sanofi S.A Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Sanofi S.A Main Business Overview
  11.4.5 Sanofi S.A Latest Developments
11.5 Novartis International AG
  11.5.1 Novartis International AG Company Information
  11.5.2 Novartis International AG Mental Disorder Treatment Product Offered
  11.5.3 Novartis International AG Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis International AG Main Business Overview
  11.5.5 Novartis International AG Latest Developments
11.6 Mylan N.V
  11.6.1 Mylan N.V Company Information
  11.6.2 Mylan N.V Mental Disorder Treatment Product Offered
  11.6.3 Mylan N.V Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Mylan N.V Main Business Overview
  11.6.5 Mylan N.V Latest Developments
11.7 Amneal Pharmaceuticals LLC
  11.7.1 Amneal Pharmaceuticals LLC Company Information
  11.7.2 Amneal Pharmaceuticals LLC Mental Disorder Treatment Product Offered
  11.7.3 Amneal Pharmaceuticals LLC Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Amneal Pharmaceuticals LLC Main Business Overview
  11.7.5 Amneal Pharmaceuticals LLC Latest Developments
11.8 Cipla Ltd
  11.8.1 Cipla Ltd Company Information
  11.8.2 Cipla Ltd Mental Disorder Treatment Product Offered
  11.8.3 Cipla Ltd Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Cipla Ltd Main Business Overview
  11.8.5 Cipla Ltd Latest Developments
11.9 Sun Pharmaceutical Industries Ltd
  11.9.1 Sun Pharmaceutical Industries Ltd Company Information
  11.9.2 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Product Offered
  11.9.3 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sun Pharmaceutical Industries Ltd Main Business Overview
  11.9.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.10 Glenmark Pharmaceuticals Limited
  11.10.1 Glenmark Pharmaceuticals Limited Company Information
  11.10.2 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Product Offered
  11.10.3 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Glenmark Pharmaceuticals Limited Main Business Overview
  11.10.5 Glenmark Pharmaceuticals Limited Latest Developments
11.11 Lupin Limited
  11.11.1 Lupin Limited Company Information
  11.11.2 Lupin Limited Mental Disorder Treatment Product Offered
  11.11.3 Lupin Limited Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Lupin Limited Main Business Overview
  11.11.5 Lupin Limited Latest Developments
11.12 Janssen Pharmaceutica
  11.12.1 Janssen Pharmaceutica Company Information
  11.12.2 Janssen Pharmaceutica Mental Disorder Treatment Product Offered
  11.12.3 Janssen Pharmaceutica Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Janssen Pharmaceutica Main Business Overview
  11.12.5 Janssen Pharmaceutica Latest Developments
11.13 Bristol Myers Squibb
  11.13.1 Bristol Myers Squibb Company Information
  11.13.2 Bristol Myers Squibb Mental Disorder Treatment Product Offered
  11.13.3 Bristol Myers Squibb Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Bristol Myers Squibb Main Business Overview
  11.13.5 Bristol Myers Squibb Latest Developments
11.14 Sumitomo Dainippon Pharma Co., Ltd
  11.14.1 Sumitomo Dainippon Pharma Co., Ltd Company Information
  11.14.2 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Product Offered
  11.14.3 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Sumitomo Dainippon Pharma Co., Ltd Main Business Overview
  11.14.5 Sumitomo Dainippon Pharma Co., Ltd Latest Developments
11.15 Acadia Healthcare
  11.15.1 Acadia Healthcare Company Information
  11.15.2 Acadia Healthcare Mental Disorder Treatment Product Offered
  11.15.3 Acadia Healthcare Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Acadia Healthcare Main Business Overview
  11.15.5 Acadia Healthcare Latest Developments
11.16 The MENTOR Network
  11.16.1 The MENTOR Network Company Information
  11.16.2 The MENTOR Network Mental Disorder Treatment Product Offered
  11.16.3 The MENTOR Network Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 The MENTOR Network Main Business Overview
  11.16.5 The MENTOR Network Latest Developments
11.17 Universal Health Services, Inc.
  11.17.1 Universal Health Services, Inc. Company Information
  11.17.2 Universal Health Services, Inc. Mental Disorder Treatment Product Offered
  11.17.3 Universal Health Services, Inc. Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Universal Health Services, Inc. Main Business Overview
  11.17.5 Universal Health Services, Inc. Latest Developments
11.18 Behavioral Health Network, Inc.
  11.18.1 Behavioral Health Network, Inc. Company Information
  11.18.2 Behavioral Health Network, Inc. Mental Disorder Treatment Product Offered
  11.18.3 Behavioral Health Network, Inc. Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Behavioral Health Network, Inc. Main Business Overview
  11.18.5 Behavioral Health Network, Inc. Latest Developments
11.19 CareTech Holdings PLC
  11.19.1 CareTech Holdings PLC Company Information
  11.19.2 CareTech Holdings PLC Mental Disorder Treatment Product Offered
  11.19.3 CareTech Holdings PLC Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 CareTech Holdings PLC Main Business Overview
  11.19.5 CareTech Holdings PLC Latest Developments
11.20 Strategic Behavioral Health
  11.20.1 Strategic Behavioral Health Company Information
  11.20.2 Strategic Behavioral Health Mental Disorder Treatment Product Offered
  11.20.3 Strategic Behavioral Health Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 Strategic Behavioral Health Main Business Overview
  11.20.5 Strategic Behavioral Health Latest Developments
11.21 Ascension Seton
  11.21.1 Ascension Seton Company Information
  11.21.2 Ascension Seton Mental Disorder Treatment Product Offered
  11.21.3 Ascension Seton Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.21.4 Ascension Seton Main Business Overview
  11.21.5 Ascension Seton Latest Developments
11.22 North Range Behavioral Health
  11.22.1 North Range Behavioral Health Company Information
  11.22.2 North Range Behavioral Health Mental Disorder Treatment Product Offered
  11.22.3 North Range Behavioral Health Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.22.4 North Range Behavioral Health Main Business Overview
  11.22.5 North Range Behavioral Health Latest Developments
11.23 Pyramid Healthcare
  11.23.1 Pyramid Healthcare Company Information
  11.23.2 Pyramid Healthcare Mental Disorder Treatment Product Offered
  11.23.3 Pyramid Healthcare Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.23.4 Pyramid Healthcare Main Business Overview
  11.23.5 Pyramid Healthcare Latest Developments
11.24 Promises Behavioral Health
  11.24.1 Promises Behavioral Health Company Information
  11.24.2 Promises Behavioral Health Mental Disorder Treatment Product Offered
  11.24.3 Promises Behavioral Health Mental Disorder Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.24.4 Promises Behavioral Health Main Business Overview
  11.24.5 Promises Behavioral Health Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Mental Disorder Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Mental Disorder Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Medications
Table 4. Major Players of Self-help Therapies
Table 5. Mental Disorder Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Mental Disorder Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Mental Disorder Treatment Market Size Market Share by Type (2020-2025)
Table 8. Mental Disorder Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Mental Disorder Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Mental Disorder Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Mental Disorder Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Mental Disorder Treatment Revenue Market Share by Player (2020-2025)
Table 13. Mental Disorder Treatment Key Players Head office and Products Offered
Table 14. Mental Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Mental Disorder Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Mental Disorder Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Mental Disorder Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Mental Disorder Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Mental Disorder Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Mental Disorder Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Mental Disorder Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Mental Disorder Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Mental Disorder Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Mental Disorder Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Mental Disorder Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Mental Disorder Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Mental Disorder Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Mental Disorder Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Mental Disorder Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Mental Disorder Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Mental Disorder Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Mental Disorder Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Mental Disorder Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Mental Disorder Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Mental Disorder Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Mental Disorder Treatment
Table 39. Key Market Challenges & Risks of Mental Disorder Treatment
Table 40. Key Industry Trends of Mental Disorder Treatment
Table 41. Global Mental Disorder Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Mental Disorder Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Mental Disorder Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Mental Disorder Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Allergan Plc Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 46. Allergan Plc Mental Disorder Treatment Product Offered
Table 47. Allergan Plc Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Allergan Plc Main Business
Table 49. Allergan Plc Latest Developments
Table 50. Eli Lilly and Company Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 51. Eli Lilly and Company Mental Disorder Treatment Product Offered
Table 52. Eli Lilly and Company Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Eli Lilly and Company Main Business
Table 54. Eli Lilly and Company Latest Developments
Table 55. VistaGen Therapeutics Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 56. VistaGen Therapeutics Mental Disorder Treatment Product Offered
Table 57. VistaGen Therapeutics Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. VistaGen Therapeutics Main Business
Table 59. VistaGen Therapeutics Latest Developments
Table 60. Sanofi S.A Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 61. Sanofi S.A Mental Disorder Treatment Product Offered
Table 62. Sanofi S.A Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sanofi S.A Main Business
Table 64. Sanofi S.A Latest Developments
Table 65. Novartis International AG Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 66. Novartis International AG Mental Disorder Treatment Product Offered
Table 67. Novartis International AG Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Novartis International AG Main Business
Table 69. Novartis International AG Latest Developments
Table 70. Mylan N.V Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 71. Mylan N.V Mental Disorder Treatment Product Offered
Table 72. Mylan N.V Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Mylan N.V Main Business
Table 74. Mylan N.V Latest Developments
Table 75. Amneal Pharmaceuticals LLC Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 76. Amneal Pharmaceuticals LLC Mental Disorder Treatment Product Offered
Table 77. Amneal Pharmaceuticals LLC Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Amneal Pharmaceuticals LLC Main Business
Table 79. Amneal Pharmaceuticals LLC Latest Developments
Table 80. Cipla Ltd Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 81. Cipla Ltd Mental Disorder Treatment Product Offered
Table 82. Cipla Ltd Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Cipla Ltd Main Business
Table 84. Cipla Ltd Latest Developments
Table 85. Sun Pharmaceutical Industries Ltd Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 86. Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Product Offered
Table 87. Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sun Pharmaceutical Industries Ltd Main Business
Table 89. Sun Pharmaceutical Industries Ltd Latest Developments
Table 90. Glenmark Pharmaceuticals Limited Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 91. Glenmark Pharmaceuticals Limited Mental Disorder Treatment Product Offered
Table 92. Glenmark Pharmaceuticals Limited Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Glenmark Pharmaceuticals Limited Main Business
Table 94. Glenmark Pharmaceuticals Limited Latest Developments
Table 95. Lupin Limited Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 96. Lupin Limited Mental Disorder Treatment Product Offered
Table 97. Lupin Limited Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Lupin Limited Main Business
Table 99. Lupin Limited Latest Developments
Table 100. Janssen Pharmaceutica Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 101. Janssen Pharmaceutica Mental Disorder Treatment Product Offered
Table 102. Janssen Pharmaceutica Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Janssen Pharmaceutica Main Business
Table 104. Janssen Pharmaceutica Latest Developments
Table 105. Bristol Myers Squibb Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 106. Bristol Myers Squibb Mental Disorder Treatment Product Offered
Table 107. Bristol Myers Squibb Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Bristol Myers Squibb Main Business
Table 109. Bristol Myers Squibb Latest Developments
Table 110. Sumitomo Dainippon Pharma Co., Ltd Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 111. Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Product Offered
Table 112. Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Sumitomo Dainippon Pharma Co., Ltd Main Business
Table 114. Sumitomo Dainippon Pharma Co., Ltd Latest Developments
Table 115. Acadia Healthcare Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 116. Acadia Healthcare Mental Disorder Treatment Product Offered
Table 117. Acadia Healthcare Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Acadia Healthcare Main Business
Table 119. Acadia Healthcare Latest Developments
Table 120. The MENTOR Network Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 121. The MENTOR Network Mental Disorder Treatment Product Offered
Table 122. The MENTOR Network Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. The MENTOR Network Main Business
Table 124. The MENTOR Network Latest Developments
Table 125. Universal Health Services, Inc. Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 126. Universal Health Services, Inc. Mental Disorder Treatment Product Offered
Table 127. Universal Health Services, Inc. Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Universal Health Services, Inc. Main Business
Table 129. Universal Health Services, Inc. Latest Developments
Table 130. Behavioral Health Network, Inc. Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 131. Behavioral Health Network, Inc. Mental Disorder Treatment Product Offered
Table 132. Behavioral Health Network, Inc. Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Behavioral Health Network, Inc. Main Business
Table 134. Behavioral Health Network, Inc. Latest Developments
Table 135. CareTech Holdings PLC Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 136. CareTech Holdings PLC Mental Disorder Treatment Product Offered
Table 137. CareTech Holdings PLC Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. CareTech Holdings PLC Main Business
Table 139. CareTech Holdings PLC Latest Developments
Table 140. Strategic Behavioral Health Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 141. Strategic Behavioral Health Mental Disorder Treatment Product Offered
Table 142. Strategic Behavioral Health Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Strategic Behavioral Health Main Business
Table 144. Strategic Behavioral Health Latest Developments
Table 145. Ascension Seton Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 146. Ascension Seton Mental Disorder Treatment Product Offered
Table 147. Ascension Seton Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Ascension Seton Main Business
Table 149. Ascension Seton Latest Developments
Table 150. North Range Behavioral Health Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 151. North Range Behavioral Health Mental Disorder Treatment Product Offered
Table 152. North Range Behavioral Health Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. North Range Behavioral Health Main Business
Table 154. North Range Behavioral Health Latest Developments
Table 155. Pyramid Healthcare Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 156. Pyramid Healthcare Mental Disorder Treatment Product Offered
Table 157. Pyramid Healthcare Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 158. Pyramid Healthcare Main Business
Table 159. Pyramid Healthcare Latest Developments
Table 160. Promises Behavioral Health Details, Company Type, Mental Disorder Treatment Area Served and Its Competitors
Table 161. Promises Behavioral Health Mental Disorder Treatment Product Offered
Table 162. Promises Behavioral Health Mental Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 163. Promises Behavioral Health Main Business
Table 164. Promises Behavioral Health Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Mental Disorder Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mental Disorder Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Mental Disorder Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Mental Disorder Treatment Sales Market Share by Country/Region (2024)
Figure 8. Mental Disorder Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Mental Disorder Treatment Market Size Market Share by Type in 2024
Figure 10. Mental Disorder Treatment in Depression
Figure 11. Global Mental Disorder Treatment Market: Depression (2020-2025) & ($ millions)
Figure 12. Mental Disorder Treatment in Bipolar Disorder
Figure 13. Global Mental Disorder Treatment Market: Bipolar Disorder (2020-2025) & ($ millions)
Figure 14. Mental Disorder Treatment in Schizophrenia
Figure 15. Global Mental Disorder Treatment Market: Schizophrenia (2020-2025) & ($ millions)
Figure 16. Mental Disorder Treatment in Dementia
Figure 17. Global Mental Disorder Treatment Market: Dementia (2020-2025) & ($ millions)
Figure 18. Mental Disorder Treatment in Post-traumatic Stress Disorder
Figure 19. Global Mental Disorder Treatment Market: Post-traumatic Stress Disorder (2020-2025) & ($ millions)
Figure 20. Mental Disorder Treatment in Others
Figure 21. Global Mental Disorder Treatment Market: Others (2020-2025) & ($ millions)
Figure 22. Global Mental Disorder Treatment Market Size Market Share by Application in 2024
Figure 23. Global Mental Disorder Treatment Revenue Market Share by Player in 2024
Figure 24. Global Mental Disorder Treatment Market Size Market Share by Region (2020-2025)
Figure 25. Americas Mental Disorder Treatment Market Size 2020-2025 ($ millions)
Figure 26. APAC Mental Disorder Treatment Market Size 2020-2025 ($ millions)
Figure 27. Europe Mental Disorder Treatment Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Mental Disorder Treatment Market Size 2020-2025 ($ millions)
Figure 29. Americas Mental Disorder Treatment Value Market Share by Country in 2024
Figure 30. United States Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Mental Disorder Treatment Market Size Market Share by Region in 2024
Figure 35. APAC Mental Disorder Treatment Market Size Market Share by Type (2020-2025)
Figure 36. APAC Mental Disorder Treatment Market Size Market Share by Application (2020-2025)
Figure 37. China Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. India Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Mental Disorder Treatment Market Size Market Share by Country in 2024
Figure 44. Europe Mental Disorder Treatment Market Size Market Share by Type (2020-2025)
Figure 45. Europe Mental Disorder Treatment Market Size Market Share by Application (2020-2025)
Figure 46. Germany Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. France Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Mental Disorder Treatment Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Mental Disorder Treatment Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Mental Disorder Treatment Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Mental Disorder Treatment Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 60. APAC Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 61. Europe Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 63. United States Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 64. Canada Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 65. Mexico Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 66. Brazil Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 67. China Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 68. Japan Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 69. Korea Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 71. India Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 72. Australia Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 73. Germany Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 74. France Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 75. UK Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 76. Italy Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 77. Russia Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 78. Egypt Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 79. South Africa Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 80. Israel Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 81. Turkey Mental Disorder Treatment Market Size 2026-2031 ($ millions)
Figure 82. Global Mental Disorder Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Mental Disorder Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Mental Disorder Treatment Market Size 2026-2031 ($ millions)